US Patent 7205329 Modulators of CRTH2 activity

Is a

Patent

Patent attributes

Current Assignee

‌

Microbia, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

72053291

Patent Inventor Names

Mark G. Currie1

Jing Jing Yang1

John Jeffrey Talley1

Yueh-Tyng Chien1

Barbara Chen1

Brian M. Cali1

Craig Zimmerman1

G. Todd Milne1

Date of Patent

April 17, 2007

Patent Application Number

111836261

Date Filed

July 18, 2005

Patent Citations Received

‌

US Patent 11986452 Methods of reducing the risk of heart failure

‌

US Patent 11690820 Methods of treating mixed dyslipidemia

‌

US Patent 11712428 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity

‌

US Patent 11712429 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

Modulators of the CRTH2 receptor and their use in the treatment of various disorders, including asthma are described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7205329 Modulators of CRTH2 activity

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7205329 Modulators of CRTH2 activity